Future of Market Access

May 25, 2022

The rise of scientific breakthroughs and innovative new technologies, spurred on by heavy investment during the COVID-19 pandemic, has drastically increased the pace of Medtech growth. Market access teams are challenged like never before to keep up with the pace of new product launches and acquisitions. Moreover, the acceleration of value-based care, shifting customer dynamics, regulatory challenges, and greater scrutiny on the cost/benefits of innovative technologies have made the role of market access even more important to driving corporate growth.

In case you missed the discussion our Health Practice Leader Josh Coleman moderated a discussion on May 25th, 2022 alongside Camille Grubbs, Senior Director of Market Access for Hologic, Suki Iyer, Director of Market Access for CareDx, Steve Kimball, National Account Manager of Exagen, and Matt Larson, Associate Director of Managed Care Marketing for Castle Biosciences, Inc.